MBTAS: Macular Buckle With Three-armed Silicone

Sponsor
Sun Yat-sen University (Other)
Overall Status
Completed
CT.gov ID
NCT02169635
Collaborator
(none)
11
1
1
13
0.8

Study Details

Study Description

Brief Summary

High myopia is characterized by prolonged axial length and posterior staphyloma, which result in choroid-retinal degeneration and vision decrease. At present, vitrectomy can lead to anatomical improvements, but an higher axial length and the presence of a sever posterior staphyloma remains to be the two most important risk factors for poor visual outcomes. For these reasons, a different surgical approach, including macular buckling, might be considered in those patients with extremely high degree of myopia, in order to counteract the traction exerted by the posterior staphyloma. Macular buckling with or without pars plana vitrectomy had been proved to be an effective way to resolve myopic staphyloma related foveoschisis, macular hole, and associated retinal detachment. In this study, we sought to investigate the safety and efficacy of a macular buckling technique using a three-armed silicone capsule to support the posterior staphyloma in high myopia.

Condition or Disease Intervention/Treatment Phase
  • Procedure: macular buckle
N/A

Detailed Description

  1. This study plans to recruit 11 participants with 6 months follow-up to assess the safety and efficacy of a newly designed macular buckle device;

  2. The macular buckle device, surgical procedure, and participants registry had been reviewed and approved by Ethics committee of Zhongshan Ophthalmic Center;

  3. Only those patients are diagnosed with severe posterior staphyloma are registered.

  4. All participants are fully informed before register;

  5. All the surgeries are performed by single qualified doctor (Lin Lu);

  6. After operation, all participant could contact the researcher via telephone, and could be assessed for any surgical related complications. If there is severe complication happened, or any person that could not tolerant the macular buckle, the implanted device will be removed;

  7. Specially assigned staff (Jinge Lu) is responsible for data collection, data management, adverse events reporting, and participant communication.

Study Design

Study Type:
Interventional
Actual Enrollment :
11 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Safety and Efficacy Study of Macular Buckle With A Three-armed Silicone Capsule to Support the Posterior Staphyloma in High Myopia.
Study Start Date :
May 1, 2013
Actual Primary Completion Date :
Jun 1, 2014
Actual Study Completion Date :
Jun 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Macula buckle

Macular buckle: perform episcleral macular buckle surgery using a three-armed silicone capsule to support the posterior staphyloma in high myopia.

Procedure: macular buckle
macular buckle with a three-armed silicone capsule

Outcome Measures

Primary Outcome Measures

  1. best corrected visual acuity [6 months]

Secondary Outcome Measures

  1. postoperative complications [6 months]

  2. Optical coherence tomography [6 months]

    Using optical coherence tomography to observe the macular area postoperatively.

Other Outcome Measures

  1. intraocular pressure [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • high myopia over -8.0 Diopter

  • axial length over 26.5 mm

  • posterior staphyloma

Exclusion Criteria:
  • single eye patients

  • retinal detachment beyond macular area

  • a history of posterior scleritis

  • a history of Glaucoma

  • active hemorrhage in the surgical eye

  • active inflammation in the surgical eye

  • any situation that might hinder the observation of macular

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhongshan Ophthalmic Center Guangzhou Guangdong China 510060

Sponsors and Collaborators

  • Sun Yat-sen University

Investigators

  • Principal Investigator: Lin Lu, MD, PhD, Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Lin Lu, Director, Fundus Disease Center of Zhongshan Ophthalmic Center, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT02169635
Other Study ID Numbers:
  • 2013meky013
First Posted:
Jun 23, 2014
Last Update Posted:
Jun 23, 2014
Last Verified:
Jun 1, 2014
Keywords provided by Lin Lu, Director, Fundus Disease Center of Zhongshan Ophthalmic Center, Sun Yat-sen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 23, 2014